Melanoma vaccines: current R&D landscape, translational hurdles, and future outlook—a perspective drawn from 442 clinical trials
BackgroundMelanoma, a highly malignant skin tumor with high metastatic propensity and poor survival in advanced stages, poses a major global public health challenge, as conventional treatments have notable limitations. Tumor immunotherapy, particularly…